Recombinant Helicobacter pylori UPF0114 protein HPSH_00970 (HPSH_00970)

What is Recombinant Helicobacter pylori UPF0114 protein HPSH_00970?

Recombinant Helicobacter pylori UPF0114 protein HPSH_00970 (UniProt ID: B2US19) is a full-length protein consisting of 178 amino acids expressed in E. coli with an N-terminal His tag. The protein belongs to the UPF0114 protein family, which remains functionally uncharacterized but is conserved across different Helicobacter pylori strains. The recombinant form is typically supplied as a lyophilized powder with greater than 90% purity as determined by SDS-PAGE .

What are the optimal storage conditions for HPSH_00970?

For long-term storage, HPSH_00970 should be stored at -20°C/-80°C with appropriate aliquoting to avoid repeated freeze-thaw cycles, which can compromise protein integrity. Working aliquots can be maintained at 4°C for up to one week. The protein is typically stored in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0. For reconstitution, it is recommended to use deionized sterile water to a concentration of 0.1-1.0 mg/mL, followed by addition of 5-50% glycerol (final concentration) for long-term storage .

How does HPSH_00970 differ from HPP12_0190, another UPF0114 protein from H. pylori?

While both HPSH_00970 and HPP12_0190 belong to the UPF0114 protein family from H. pylori, they exhibit subtle differences in their amino acid sequences that may reflect strain-specific adaptations. HPSH_00970 consists of 178 amino acids (UniProt ID: B2US19), whereas HPP12_0190 has 177 amino acids (UniProt ID: B6JPT9). Sequence alignment reveals high similarity with key differences at positions:

These differences may influence protein folding, membrane integration, or interaction capabilities, warranting comparative functional studies between the two proteins .

What approaches can be used to elucidate the function of HPSH_00970?

As a protein of unknown function (UPF), determining the role of HPSH_00970 requires a multi-faceted approach:

• Structural analysis: Utilize techniques such as X-ray crystallography, NMR spectroscopy, or AI-based structure prediction tools like AlphaFold2 to determine the three-dimensional structure, which may provide insights into function .

• Protein-protein interaction studies: Employ co-immunoprecipitation, yeast two-hybrid screening, or proximity labeling methods to identify interaction partners within H. pylori.

• Gene knockout/knockdown: Create HPSH_00970 deletion mutants in H. pylori to observe phenotypic changes in bacterial growth, virulence, or stress response.

• Comparative genomics: Analyze conservation patterns across bacterial species to infer functional importance based on evolutionary conservation .

• Localization studies: Use fluorescent protein tagging or immunolocalization to determine the subcellular localization, which can provide functional clues.

How can I validate antibody specificity against HPSH_00970?

Antibody validation for HPSH_00970 should follow a systematic approach:

• Western blot analysis: Test antibody against purified recombinant HPSH_00970 alongside negative controls (E. coli lysate without the recombinant protein) and positive controls (H. pylori lysate).

• Cross-reactivity assessment: Evaluate potential cross-reactivity with the closely related HPP12_0190 protein by testing against both recombinant proteins simultaneously.

• Epitope mapping: Determine the specific epitope(s) recognized by the antibody using peptide arrays or deletion mutants.

• Immunoprecipitation efficiency: Quantify the percentage of target protein successfully immunoprecipitated from complex mixtures.

• Validation in knockout models: Test antibody specificity in HPSH_00970 knockout H. pylori strains to confirm absence of signal.

What is the optimal protocol for recombinant HPSH_00970 reconstitution?

The optimal reconstitution protocol for HPSH_00970 involves several critical steps:

• Briefly centrifuge the vial prior to opening to ensure all lyophilized material is at the bottom.

• Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL at room temperature, gently mixing until completely dissolved.

• For long-term storage, add glycerol to a final concentration of 5-50% (optimally 50%).

• Aliquot the reconstituted protein into sterile microcentrifuge tubes to minimize freeze-thaw cycles.

• Flash freeze aliquots in liquid nitrogen before transferring to -20°C/-80°C storage .

This methodology ensures maximum retention of protein activity and structural integrity throughout multiple experimental uses.

What are effective methods for studying membrane association of HPSH_00970?

HPSH_00970's amino acid sequence suggests it may be a membrane-associated protein. Effective methods for investigating this characteristic include:

• Membrane fractionation: Separate bacterial membrane fractions (inner and outer membranes) using sucrose gradient ultracentrifugation followed by western blot analysis to determine HPSH_00970 localization.

• Hydrophobicity analysis: Computational prediction of transmembrane domains using programs like TMHMM, Phobius, or HMMTOP to identify potential membrane-spanning regions.

• Protease protection assays: Treat intact bacterial cells with proteases that cannot penetrate the membrane, then analyze which protein regions are protected versus cleaved.

• Fluorescent protein fusion: Create GFP-HPSH_00970 fusion proteins for live-cell imaging to visualize membrane localization patterns.

• Lipid binding assays: Assess direct interaction with specific membrane lipids using protein-lipid overlay assays or liposome flotation assays.

How can HPSH_00970 be utilized in H. pylori pathogenesis studies?

HPSH_00970's potential roles in H. pylori pathogenesis can be investigated through several research applications:

• Host-pathogen interaction studies: Determine if HPSH_00970 interacts with host cell receptors or immune system components using pull-down assays or surface plasmon resonance.

• Colonization models: Compare colonization efficiency between wild-type and HPSH_00970-deficient H. pylori strains in cell culture or animal models.

• Immune response analysis: Evaluate host immune responses to purified HPSH_00970 protein using cytokine profiling and immune cell activation assays.

• Drug target validation: Assess HPSH_00970 as a potential therapeutic target by screening small molecule inhibitors or antibodies that disrupt its function .

• Biofilm formation: Investigate the role of HPSH_00970 in H. pylori biofilm development, which contributes to antibiotic resistance and persistent infection.

What approaches can be used to investigate post-translational modifications of HPSH_00970?

Post-translational modifications (PTMs) can significantly impact protein function. To investigate PTMs in HPSH_00970:

• Mass spectrometry analysis: Perform LC-MS/MS on purified native HPSH_00970 from H. pylori to identify PTMs such as phosphorylation, glycosylation, or acetylation.

• Site-directed mutagenesis: Create mutant versions where predicted modification sites are altered to amino acids that cannot be modified.

• Modification-specific antibodies: Utilize antibodies that specifically recognize common PTMs to detect modified forms of HPSH_00970.

• 2D gel electrophoresis: Separate protein isoforms based on charge and mass differences resulting from PTMs.

• In vitro modification assays: Test whether HPSH_00970 can serve as a substrate for known H. pylori modification enzymes.

What are common issues in working with recombinant HPSH_00970 and how can they be addressed?

Several challenges may arise when working with recombinant HPSH_00970:

• Protein aggregation: If aggregation occurs after reconstitution, try reducing protein concentration, adding mild detergents (0.05% Tween-20), or optimizing buffer conditions (pH, salt concentration).

• Loss of activity during storage: Minimize freeze-thaw cycles by creating single-use aliquots and ensure proper glycerol concentration (recommended 50%) for freezing .

• Non-specific binding in assays: Include appropriate blocking agents (BSA, non-fat milk) and consider pre-clearing samples when performing immunoprecipitation or pull-down assays.

• Precipitation during buffer exchange: Perform buffer exchanges gradually with stepwise dialysis or use spin concentrators with lower centrifugation speeds.

• Batch-to-batch variation: Always include internal controls and standardize protein quantification methods across experiments.

How can I assess the structural integrity of purified HPSH_00970?

To evaluate whether purified HPSH_00970 maintains its native structural properties:

• Circular dichroism (CD) spectroscopy: Measure secondary structure content to confirm proper folding.

• Size exclusion chromatography: Analyze elution profile to detect aggregation or oligomerization states.

• Dynamic light scattering (DLS): Determine size distribution to identify potential aggregation.

• Thermal shift assays: Assess protein stability under different buffer conditions using fluorescent dyes that bind to hydrophobic regions exposed during unfolding.

• Activity assays: If function becomes known, develop functional assays to confirm biological activity as the ultimate measure of structural integrity.